Last update 08 May 2025

Hangzhou Hetai Jianyu Biotechnology Co. Ltd.

Private Company|2021|Zhejiang Sheng, China|
healthytide.cn

Overview

Basic Info

Introduction
Hangzhou Healthytide Biotechnology Co., LTD. leverages its foundational technology of high-throughput biological screening with a proprietary library of diverse peptide entities, concentrating on the discovery and development of innovative structured peptide-based therapeutic molecules.

Tags

Neoplasms
Nervous System Diseases
Endocrinology and Metabolic Disease
Diagnostic radiopharmaceuticals
Peptide Conjugate Radionuclide
Peptide drug conjugates

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Neoplasms5
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Top 5 Drug TypeCount
Diagnostic radiopharmaceuticals4
Peptide Conjugate Radionuclide4
Peptide drug conjugates1

Related

5
Drugs associated with Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
RDC-Pancreatic Cancer(HealthyTide)
Target-
Mechanism
Diagnostic imaging enhancers
Active Org.
Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Originator Org.
Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Active Indication
Pancreatic Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
RDC-Lung Cancer(HealthyTide)
Target-
Mechanism
Diagnostic imaging enhancers
Active Org.
Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Originator Org.
Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Active Indication
Lung Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
RDC-Solid tumors(HealthyTide)
Target-
Mechanism
Diagnostic imaging enhancers
Active Org.
Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Originator Org.
Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Active Indication
Solid tumor
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Login to view more data
100 Deals associated with Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Login to view more data
100 Translational Medicine associated with Hangzhou Hetai Jianyu Biotechnology Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
3
2
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
RDC-Lung Cancer(HealthyTide)
Lung Cancer
More
Preclinical
RDC-Pancreatic Cancer(HealthyTide)
Pancreatic Cancer
More
Preclinical
PDC-Solid tumors(HealthyTide)
Solid tumor
More
Discovery
RDC-Glioma (HealthyTide)
Glioma
More
Discovery
RDC-Solid tumors(HealthyTide)
Solid tumor
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free